New Liver Cancer Drug To Be Tested at Scripps MD Anderson

Experimental drug may improve response to immune therapy

Doctors examine X-rays, looking for signs of liver cancer.

Experimental drug may improve response to immune therapy

Darren Sigal, MD, a hematologist and oncologist at Scripps MD Anderson Cancer Center, was recently featured in a news article discussing a new liver cancer drug that the US Food and Drug Administration (FDA) has approved for testing in patients.The new drug is to be tested at Scripps MD Anderson Cancer Center.


Read the article in The San Diego Union-Tribune: Experimental liver cancer drug developed at Scripps Research cleared for testing

Media Contact

Keith Darce
858-678-7121
darce.keith@scrippshealth.org
Follow me: @KeithDarce